NCT05241483 (AI - diseases) is a clinical trial of mesure valition in Predictive Value of Tests, sponsored by Setint AI Robotic Sistem Egitim ve Danısmanlık San. Tic. A.S..

Who is sponsoring NCT05241483?

NCT05241483 is sponsored by Setint AI Robotic Sistem Egitim ve Danısmanlık San. Tic. A.S..

What drugs are being tested in NCT05241483?

Interventions in NCT05241483: mesure valition.

What condition does NCT05241483 study?

NCT05241483 studies Predictive Value of Tests, Vital Signs, Laboratory Critical Values, Relative Value Scales, Reference Values.

Is NCT05241483 still recruiting?

NCT05241483 is currently status unknown. Last updated 7 March 2022.

Last reviewed 2022-03-07 · How we verify

NCT05241483: AI - diseases

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Remote Patient Monitoring and Detection of Possible Diseases With Artificial Intelligence Telemedicine System

Status unknown Last updated 7 March 2022

What this trial tests

trial testing mesure valition in Predictive Value of Tests in 1,000 participants. Status unknown.

Timeline

30 March 2020

Primary endpoint
20 July 2021

30 December 2022

Quick facts

Lead sponsor	Setint AI Robotic Sistem Egitim ve Danısmanlık San. Tic. A.S.
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	30 March 2020
Primary completion	20 July 2021
Estimated completion	30 December 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

mesure valition

Conditions studied

Predictive Value of Tests — all drugs for Predictive Value of Tests →
Vital Signs — all drugs for Vital Signs →
Laboratory Critical Values — all drugs for Laboratory Critical Values →
Relative Value Scales — all drugs for Relative Value Scales →

Sponsor

Setint AI Robotic Sistem Egitim ve Danısmanlık San. Tic. A.S.

Who can join

Eligibility, any sex, with Predictive Value of Tests or Vital Signs. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Remote patient monitoring and detection of possible diseases with Artificial Intelligence Telemedicine System

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Predictive Value of Tests

Currently open trials in the same condition.

NCT06842940 — Slew Rate As a Predictor for Optimal Lead Fixation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05241483 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Setint AI Robotic Sistem Egitim ve Danısmanlık San. Tic. A.S.
Last refreshed: 7 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05241483.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing